Vikram Khurana, MD, PhD, is Chief of the Division of Movement Disorders at Brigham and Women’s Hospital and Harvard Medical Schoo. He is principal faculty at the Ann Romney Center and Harvard Stem Cell Institute, associate member of the Broad Institute of Harvard and MIT, and senior advisor to Yumanity Therapeutics, a company he co-founded. His clinical and research interests relate to neurodegenerative disorders focusing on Parkinson’s disease and related dementias, rarer disorders including multiple system atrophy and ataxias.
His current research continues to bring stem-cell technologies toward personalized and precise diagnostics and therapeutics for neurodegenerative disorders. Dr. Khurana’s research has been recognized through awards from the American Academy of Neurology, American Australian Association, Department of Defense, Multiple System Atrophy Coalition, National Ataxia Foundation Parkinson’s Disease Foundation and the NIH. In 2018, he was named a Robertson Investigator of the New York Stem Cell Foundation.
Dr. Khurana is a board-certified neurologist. He earned his medical degree at the University of Sydney, Australia, and came to Boston as a Fulbright Scholar in 2001, obtaining his doctorate in neurobiology from Harvard University in 2006. He completed his neurology residency at Brigham and Women’s and Massachusetts General Hospitals, and fellowship in movement disorders and ataxia at Massachusetts General Hospital.